Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
06/2002
06/06/2002WO2002044723A2 Method for diagnosing a predisposition of psychosis in a progeny
06/06/2002WO2002044722A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
06/06/2002WO2002044721A1 Analytic method and reagent for use thereof
06/06/2002WO2002044720A2 Membrane molecule indicator compositions and methods
06/06/2002WO2002044719A1 A screening assay for detecting chromosome rearrangements or recombinations
06/06/2002WO2002044718A2 S.aureus protein staau r2, gene encoding it and uses thereof
06/06/2002WO2002044717A1 Animal model for flaviviridae infection
06/06/2002WO2002044716A1 Method of monitoring uterine status using uterine natural killer cells
06/06/2002WO2002044715A1 Methods for efficiently minig broad data sets for biological markers
06/06/2002WO2002044714A2 System and method for integrated analysis of data for characterizing carbohydrate polymers
06/06/2002WO2002044713A2 Flow through device for two dimensional incubation and/or hybridization on solid supports
06/06/2002WO2002044711A1 Method and reagent for measuring component using weak chemical light emission
06/06/2002WO2002044705A1 Biosensor, measuring instrument for biosensor, and method of quantifying substrate
06/06/2002WO2002044704A2 Catalytic carbon monoxide sensor and detection method
06/06/2002WO2002044702A2 Adsorption based carbon monoxide sensor and method
06/06/2002WO2002044701A2 Heating device
06/06/2002WO2002044698A1 System and method for gas discharge spectroscopy
06/06/2002WO2002044696A1 Method and apparatus for monitoring environment and apparatus for producing semiconductor
06/06/2002WO2002044695A1 Methods and apparatus for detecting and quantifying lymphocytes with optical biodiscs
06/06/2002WO2002044694A2 Permeability measurement
06/06/2002WO2002044692A1 Apparatus for analyzing the characteristics of ground products
06/06/2002WO2002044688A2 Analyzing molecular diversity by total pharmacophore diversity
06/06/2002WO2002044686A2 Predictive method for polymers
06/06/2002WO2002044427A2 Cell based triple readout assay systems for identifying compounds that effect transcription
06/06/2002WO2002044422A2 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits
06/06/2002WO2002044420A2 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
06/06/2002WO2002044419A2 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
06/06/2002WO2002044418A2 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
06/06/2002WO2002044417A2 Expression analysis of inhibitor of differentiation nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
06/06/2002WO2002044416A2 Sulfonated diarylrhodamine dyes as fluorescent labels
06/06/2002WO2002044412A1 Method and apparatus using a surface-selective nonlinear optical technique for detection of probe-target interactions
06/06/2002WO2002044404A1 Methods for diagnosing individuals with an increased risk to develop a deficiency based on mdr1 gene polymorphism
06/06/2002WO2002044400A2 Compositions and methods for extracting a nucleic acid
06/06/2002WO2002044384A2 T-cell epitope of the papillomavirus l1 and e7 protein and use thereof in diagnostics and therapy
06/06/2002WO2002044380A2 Master bone formation transcription factor: compositions and methods of use
06/06/2002WO2002044379A2 Transforming growth factor-beta-related molecules and uses thereof
06/06/2002WO2002044377A2 Obp1:a protein selectively expressed in osteoblasts
06/06/2002WO2002044374A2 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
06/06/2002WO2002044372A2 Nucleotide and protein sequence of helios 3 and methods of use
06/06/2002WO2002044370A1 Human cervical cancer 2 protooncogene and protein encoded therein
06/06/2002WO2002044367A1 Method of screening remedy for diabetes
06/06/2002WO2002044361A2 Eukaryotic expression libraries based on double lox recombination and methods of use
06/06/2002WO2002044342A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof
06/06/2002WO2002044336A2 Method of making a protein polymer and uses of the polymer
06/06/2002WO2002044335A2 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions
06/06/2002WO2002044330A2 Crystal structure of rotavirus nsp4 peptide
06/06/2002WO2002044327A2 Method and apparatus for protein manipulation
06/06/2002WO2002044326A2 Methods for detection of a target nucleic acid by capture
06/06/2002WO2002044321A2 Rna interference mediating small rna molecules
06/06/2002WO2002044320A2 Human elongase genes and uses thereof
06/06/2002WO2002044319A2 Spatially directed ejection of cells from a carrier fluid
06/06/2002WO2002044216A1 Probes for identifying cancer-specific antigens
06/06/2002WO2002044210A2 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
06/06/2002WO2002044209A2 Cytonkine receptor zcytor19
06/06/2002WO2002044208A1 Methods of screening for agonists and antagonists of the hneaa81 receptor
06/06/2002WO2002044205A2 Peptides from ag85 of mycobacterium and uses thereof
06/06/2002WO2002044195A2 Method for base sequencing and biologically active nucleic acids
06/06/2002WO2002043870A1 Microsystem for the dielectric and optical manipulation of particles
06/06/2002WO2002043866A2 Apparatus and methods for separating components of particulate suspension
06/06/2002WO2002043864A2 Devices and methods for biochip multiplexing
06/06/2002WO2002043855A1 Static micro-array of biological or chemical probes immobilised on a support by magnetic attraction
06/06/2002WO2002043829A2 Method and device for continuously treating waste water of industrial origin by water vapour stripping
06/06/2002WO2002043828A2 Microtiter plate format device and methods for separating differently charged molecules using an electric field
06/06/2002WO2002043779A2 Use of acacia gum (arabic gum) to isolate and preserve biological material
06/06/2002WO2002043773A2 Tissue specific prodrugs
06/06/2002WO2002043765A2 Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
06/06/2002WO2002043758A2 Uses of mammalian genes and related reagents
06/06/2002WO2002043754A1 Proteins binding hcv and their medical, diagnostic and purification use
06/06/2002WO2002043578A2 Determination of risk and treatment of complications of prematurity
06/06/2002WO2002043575A2 Zinc alpha-2-glycoprotein as indicator of cancer
06/06/2002WO2002043572A2 Erythropoietin and erythropoietin receptor expression in human cancer
06/06/2002WO2002043568A2 Identification of compounds that potentiate the activity of muscarinic potassium channels
06/06/2002WO2002043561A2 Measuring haematocrit in blood vessels
06/06/2002WO2002043559A2 Methods and kits for diagnosis of schizophrenia
06/06/2002WO2002025275A3 Micro-invasive method for painless detection of analytes in extracellular space
06/06/2002WO2002024144A3 Use of transcription factors for treating inflammation and other diseases
06/06/2002WO2002020555A3 Hiv peptides from tat, rev and wef conserved regions and their application as e.g.vaccine components
06/06/2002WO2002020435A3 Generation of combinatorial libraries and assessment thereof by deconvolution
06/06/2002WO2002018940A3 Device for measuring analyte concentration in a fluid
06/06/2002WO2002017900A9 Modulators of us28 (chemokines) for treating cytomegalovirus infections
06/06/2002WO2002014860A8 Functional protein arrays
06/06/2002WO2002010764A3 SPECIFIC BINDING AGENTS FOR KSHV vIL-6 THAT NEUTRALIZE A BIOLOGICAL ACTIVITY
06/06/2002WO2002006510A3 Photoselection of nucleic acid ligands
06/06/2002WO2001098359A3 Cyr61 as a target for treatment and diagnosis of breast cancer
06/06/2002WO2001096834A3 Biosensor and deposit sensor for monitoring biofilm and other deposits
06/06/2002WO2001096557A3 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same
06/06/2002WO2001094549A3 Methods of differentiating and protecting cells by modulating the p38/mef2 pathway
06/06/2002WO2001094528A3 Visual-servoing optical microscopy
06/06/2002WO2001090360A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
06/06/2002WO2001089788A3 Patterning of surfaces utilizing microfluidic stamps including three-dimensionally arrayed channel networks
06/06/2002WO2001088116A9 Method of modulating activation of lymphocytes via modulation of pituitary tumor transforming gene, related screeining methods
06/06/2002WO2001085901A3 Microphysiometer
06/06/2002WO2001077668A3 Proteomic analysis using active-site directed probes
06/06/2002WO2001075453A3 Methods involving induced dimerisation by cellular components
06/06/2002WO2001071361A3 Constitutive androstane receptor
06/06/2002WO2001069213A3 Optical probes an methods for spectral analysis
06/06/2002WO2001067129A3 Epoxide polymer surfaces
06/06/2002WO2001067092A3 Continuous analyzer of volatile organic compounds, device and method for continuously assessing the quality of inside ambient air and use of said device for monitoring a ventilation installation
06/06/2002WO2001066172A3 Extracorporeal blood processing method and apparatus
06/06/2002WO2001064907A3 Lipid metabolism enzymes
1 ... 2810 2811 2812 2813 2814 2815 2816 2817 2818 2819 2820 2821 2822 2823 2824 2825 2826 2827 2828 2829 2830 ... 3937